3rd Annual European Congress on Immunotherapies in Cancer™ — Call for Poster Abstracts!
The program chairs invite you to submit your abstracts for the 3rd Annual European Congress on Immunotherapies in Cancer™ to be held 21-22 September 2018 at Hilton Barcelona, Barcelona, Spain. Share your research or best practices with your peers.
The hotel is expected to sell out and likely to do so before the discounted cut-off date of the 17 August 2018. Reservations may be made online here.
The deadline for submission is 1 September 2018, 11:59 AM US EDT (5:59 PM CEDT).
Your abstract should be a short description of your work focused on immunotherapies in cancer and contain all the elements necessary to define your goals and results to the reader. Authors will be required to disclose all financial relationships through the online system, helping to ensure quality and unbiased presentations. The formal poster session is not designated for credit. All poster abstracts must be submitted electronically through the congress' online abstract submission system. Trial-in-progress and encore abstracts are accepted.
Categories of submission can include:
The program chairs will evaluate the scientific quality of the submitted abstracts on the basis of the following criteria: novelty of the research, significance of the findings, and clarity. Incomplete abstracts will not be reviewed. Notification of acceptance, or regret, will be delivered via e-mail to the presenter(s) of each poster abstract by mid-September
If accepted for presentation, abstracts and posters will be available for viewing online on the 2018 congress website during and after the conference. The posters will be displayed for the length of the conference.
For accepted submissions, an author is required to be present during the poster session. The presentation should reflect the submitted abstract title, authorship, and content of the submitted abstract.
All presenters must register to attend the 3nd Annual European Congress on Immunotherapies in Cancer™- Please click here to register.
Components of the Abstract Body-Limit: 2500 Characters
Please submit any questions pertaining to abstract submissions to email@example.com using the subject line "European Congress on Immunotherapies in Cancer™ Abstract QUESTION."
Author Consent and Waiver of Claims
Cancer Summaries and Commentaries™: Update from Atlanta – Advances in the Treatment of Multiple Myeloma
Feb 28, 2019
Feb 28, 2019
Feb 28, 2019
23rd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma
February 28, 2019 - March 3, 2019